Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis
出版年份 2023 全文链接
标题
Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis
作者
关键词
-
出版物
Cancer Discovery
Volume 13, Issue 5, Pages 1100-1115
出版商
American Association for Cancer Research (AACR)
发表日期
2023-02-23
DOI
10.1158/2159-8290.cd-22-1180
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- 18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging for the diagnosis of immune checkpoint inhibitor-associated myocarditis
- (2022) Stéphane Ederhy et al. Archives of Cardiovascular Diseases
- Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database
- (2022) Lee S. Nguyen et al. Nature Communications
- Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditis
- (2022) John R. Power et al. Archives of Cardiovascular Diseases
- Reversal of immune-checkpoint inhibitor fulminant myocarditis using personalized-dose-adjusted abatacept and ruxolitinib: proof of concept
- (2022) Lee S Nguyen et al. Journal for ImmunoTherapy of Cancer
- Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registry
- (2022) Joseph Nowatzke et al. EUROPEAN JOURNAL OF CANCER
- T cells specific for α-myosin drive immunotherapy-related myocarditis
- (2022) Margaret L. Axelrod et al. NATURE
- Role of Cardiac Imaging in the Diagnosis of Immune Checkpoints Inhibitors Related Myocarditis
- (2021) Stéphane Ederhy et al. Frontiers in Oncology
- Immune checkpoint inhibitor myocarditis: elucidating the spectrum of disease through endomyocardial biopsy
- (2021) Nicolas L. Palaskas et al. EUROPEAN JOURNAL OF HEART FAILURE
- Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor–Associated Myocarditis
- (2021) Lorenz H. Lehmann et al. JAMA Cardiology
- Comparative Transcriptomics of Immune Checkpoint Inhibitor Myocarditis Identifies Guanylate Binding Protein 5 and 6 Dysregulation
- (2021) Daniel Finke et al. Cancers
- Electrocardiographic Manifestations of Immune Checkpoint Inhibitor Myocarditis
- (2021) John R. Power et al. CIRCULATION
- Interferon-Gamma–Producing CD8+ Tissue Resident Memory T Cells Are a Targetable Hallmark of Immune Checkpoint Inhibitor–Colitis
- (2021) Sarah C. Sasson et al. GASTROENTEROLOGY
- Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update
- (2021) Bryan J. Schneider et al. JOURNAL OF CLINICAL ONCOLOGY
- Case Series of Steroid-Resistant Immune Checkpoint Inhibitor Associated Myocarditis: A Comparative Analysis of Corticosteroid and Tofacitinib Treatment
- (2021) Cong Wang et al. Frontiers in Pharmacology
- Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis
- (2020) Lili Zhang et al. EUROPEAN HEART JOURNAL
- Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
- (2020) Robert Zeiser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune checkpoint inhibitor-induced myositis, the earliest and most lethal complication among rheumatic and musculoskeletal toxicities
- (2020) Yves Allenbach et al. AUTOIMMUNITY REVIEWS
- Combined anti-fibrotic and anti-inflammatory properties of JAK-inhibitors on macrophages in vitro and in vivo: Perspectives for scleroderma-associated interstitial lung disease
- (2020) Alain Lescoat et al. BIOCHEMICAL PHARMACOLOGY
- Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy
- (2020) Adrienne M. Luoma et al. CELL
- Clinical Pharmacology and Interplay of Immune Checkpoint Agents: A Yin-Yang Balance
- (2020) Arthur Geraud et al. Annual Review of Pharmacology and Toxicology
- Inhibition of cytokine signaling by ruxolitinib and implications for COVID-19 treatment
- (2020) Swamy Yeleswaram et al. CLINICAL IMMUNOLOGY
- Efficacy and outcome of Tofacitinib in Immune checkpoint inhibitor colitis.
- (2020) Shrinivas Bishu et al. GASTROENTEROLOGY
- A genetic mouse model recapitulates immune checkpoint inhibitor-associated myocarditis and supports a mechanism-based therapeutic intervention
- (2020) Spencer C Wei et al. Cancer Discovery
- Inflammatory myositis in cancer patients receiving immune checkpoint inhibitors
- (2020) Jeffrey Aldrich et al. Arthritis & Rheumatology
- Mechanisms of Action of Ruxolitinib in Murine Models of Hemophagocytic Lymphohistiocytosis
- (2019) Sabrin Albeituni et al. BLOOD
- Treatment of pembrolizumab-induced cutaneous lesions with ruxolitinib
- (2019) Chia-Yu Chen et al. EUROPEAN JOURNAL OF CANCER
- ERS Statement on Respiratory Muscle Testing at Rest and during Exercise
- (2019) Pierantonio Laveneziana et al. EUROPEAN RESPIRATORY JOURNAL
- Myocarditis in the Setting of Cancer Therapeutics
- (2019) Marc P. Bonaca et al. CIRCULATION
- Abatacept for Severe Immune Checkpoint Inhibitor–Associated Myocarditis
- (2019) Joe-Elie Salem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
- (2018) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
- (2018) Syed S. Mahmood et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Immune Checkpoint Inhibitor–Associated Myositis
- (2018) Céline Anquetil et al. CIRCULATION
- Deep phenotyping of immune cell populations by optimized and standardized flow cytometry analyses
- (2018) Fabien Pitoiset et al. CYTOMETRY PART A
- Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors
- (2018) Daniel Y. Wang et al. JAMA Oncology
- Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study
- (2018) Joe-Elie Salem et al. LANCET ONCOLOGY
- Modeling of Lung Function Recovery in Neuralgic Amyotrophy With Diaphragm Impairment
- (2017) Brenda L Rice et al. Respiratory Care
- Fulminant Myocarditis with Combination Immune Checkpoint Blockade
- (2016) Douglas B. Johnson et al. NEW ENGLAND JOURNAL OF MEDICINE
- The JAK inhibitor, tofacitinib, reduces the T cell stimulatory capacity of human monocyte-derived dendritic cells
- (2013) Satoshi Kubo et al. ANNALS OF THE RHEUMATIC DISEASES
- The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo
- (2013) A. Heine et al. BLOOD
- Time-Varying Belatacept Exposure and Its Relationship to Efficacy/Safety Responses in Kidney-Transplant Recipients
- (2012) Z Zhou et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Assessment of Belatacept-Mediated Costimulation Blockade Through Evaluation of CD80/86-Receptor Saturation
- (2009) Robert Latek et al. TRANSPLANTATION
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now